Biogen's High-Dose Spinraza Hits Regulatory Snag: FDA Issues Refusal to File
American Express Platinum: Navigating Fatigue for Future Growth
Unlocking Apple's Hidden Potential: Why Analysts Say the Street is Seriously Underestimating AAPL's Next Growth Wave
Micron Soars: AI Revolution Propels Stock to New Heights, Analyst Sees Massive Upside
FuelCell Energy Soars: Hopes Ignited, But Analysts Warn of Sky-High Valuation
Unlocking Potential: Bright Minds Biosciences Poised for Growth Amidst Vast Patient Needs
PTC Therapeutics: A New Titan Rising to Challenge BioMarin's Reign in Rare Disease Treatment
Dianthus Unlocks Promising Future with Breakthrough Trial Results and Analyst Acclaim
Phreesia's Epic Alliance Deepens: A Game Changer or Integration Hurdle?
Ciena Soars to New Heights with Record Orders: Analyst Raises Forecasts on Unprecedented Visibility
A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress
Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling
Telix Pharmaceuticals Faces Second Major FDA Hurdle for Critical Kidney Cancer Diagnostic
The Global Skies Await: Are US eVTOL Pioneers Falling Behind in the Race for Future Flight?
Kyverna Therapeutics: Charting a Course for Revolutionary Autoimmune CAR T Therapy by 2026
Unlocking Value: Why Analysts See Further Divestitures on Medtronic's Horizon
Carlsmed's Personalized Spine Implants Revolutionize Care with Landmark Reimbursement Approval
Buffett's Bold Bet: Why Berkshire Hathaway Is Doubling Down on UnitedHealth